Globotriaosylceramide

Globotriaosylceramide (Gb3), also known as ceramide trihexoside, is a glycosphingolipid consisting of a ceramide and three sugar molecules: two galactose units and one glucose unit. It is a member of the glycosphingolipid family, which are essential components of cell membranes and play a crucial role in cell signaling and interaction.
Structure[edit]
Globotriaosylceramide is composed of a hydrophobic ceramide backbone linked to a hydrophilic trisaccharide chain. The ceramide portion consists of a long-chain base (sphingosine) and a fatty acid, while the trisaccharide chain is made up of two galactose molecules and one glucose molecule.
Function[edit]
Gb3 is primarily found in the plasma membrane of cells, particularly in the kidney, heart, and nervous system. It is involved in various cellular processes, including cell adhesion, signal transduction, and the formation of lipid rafts. Gb3 also serves as a receptor for certain bacterial toxins, such as the Shiga toxin produced by Escherichia coli.
Clinical Significance[edit]
The accumulation of globotriaosylceramide in tissues is a hallmark of Fabry disease, a rare genetic disorder caused by mutations in the GLA gene that lead to a deficiency of the enzyme alpha-galactosidase A. This enzyme is responsible for breaking down Gb3, and its deficiency results in the progressive buildup of Gb3 in various organs, leading to symptoms such as pain, kidney dysfunction, heart disease, and stroke.
Diagnosis and Treatment[edit]
Diagnosis of Fabry disease typically involves measuring the activity of alpha-galactosidase A in blood or tissue samples, as well as genetic testing to identify mutations in the GLA gene. Treatment options include enzyme replacement therapy (ERT) with recombinant alpha-galactosidase A, which helps reduce Gb3 accumulation and alleviate symptoms. Other treatments may include pain management, kidney dialysis, and heart medications.
Related Pages[edit]
- Fabry disease
- Glycosphingolipid
- Alpha-galactosidase A
- GLA gene
- Shiga toxin
- Lipid raft
- Plasma membrane
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian